Enter your search terms:
Top

Uncategorized

Court Ruling in Favor of Aquestive Therapeutics Enjoining Dr. Reddy’s Laboratories from Launching its Generic Suboxone Product

WARREN, N.J., July 16, 2018 /PRNewswire/ -- Aquestive Therapeutics ("Aquestive") announces today that the U.S. District Court for the District of New Jersey has granted Aquestive together with Indivior PLC (LON: INDV) and its U.S. subsidiary, Indivior Inc., a preliminary injunction against Dr. Reddy's Laboratories ("DRL"), mandating the restrictions...

Aquestive Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Clobazam Oral Soluble Film to Treat Lennox-Gastaut Syndrome

WARREN, N.J., January 18, 2018 – Aquestive Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application for clobazam Oral Soluble Film (clobazam OSF) for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS)...

John T. Maxwell Appointed CFO

MONOSOL RX APPOINTS JOHN T. MAXWELL AS CHIEF FINANCIAL OFFICER WARREN, N.J., January 24, 2017 – MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to improve patient outcomes and to address unmet needs, today announced the appointment of John T. Maxwell as...

Patent Infringement Suit Against BDSI

COMPLAINT ALLEGES INFRINGEMENT ON MULTIPLE CLAIMS IN MONOSOL RX’S U.S. PATENT NO. 8,765,167 BY BDSI’S BELBUCA™ WARREN, N.J., January 13, 2017 – MonoSol Rx, a specialty pharmaceutical company utilizing its PharmFilm® drug delivery technology to improve patient outcomes and to address unmet needs, today filed a...